USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: INHIBIKASE THERAPEUTICS
Address: 3350 Riverwood Pkwy
Atlanta, GA 30339-6451
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $565,846.00 2

Award List:

PML antiviral for AIDS

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Milton H. Werner
Award Amount: $265,846.00
Abstract:
DESCRIPTION (provided by applicant): Inhibikase Therapeutics is an early stage biopharmaceutical company developing a novel strategy for treating infectious disease that occurs in AIDS patients. The Company seeks to create an anti-infective product for tr eatment of JC viral infection, which leads… More

System for multidimensional analysis of growth and migration of neurons and neuro

Award Year / Program / Phase: 2013 / SBIR / Phase I
Agency: HHS
Principal Investigator: Milton H. Werner – 678-392-3419
Award Amount: $300,000.00
Abstract:
DESCRIPTION (provided by applicant): Inhibikase Therapeutics is a clinical stage, biopharmaceutical company that has developed a host- targeted mechanism of action to treat AIDS-related and drug-induced progressive multifocal leukoencephalopathy (PML). PMLis a demyelinating disease of the central… More